Comunicato stampa
TherVacB Project Begins Patient Trial to Advance Curative Strategy for Chronic Hepatitis B
Chronic hepatitis B virus (HBV) infection remains a significant global health concern, affecting an estimated 254 million people worldwide and contributing to over one million deaths each year through liver failure and liver cancer.
Hope for Hepatitis B patients
New research project to cure hepatitis B patients under the European Horizon 2020 programme.
Logo del progetto
Scaricare il logo di TherVacB: qui
Extra
Guarda il nostro film d’animazione per capire la missione e l’approccio del progetto TherVacB! qui